Remove us-news donald-trump-trials
article thumbnail

Scientists urge Pfizer to delay COVID-19 vaccine filing

pharmaphorum

Bloomberg Law has seen a letter from more than 60 scientists and bioethicists calling for further safety monitoring following reports that the trial could yield conclusive results in October. Trump last week told a news conference at the White House: “We’re looking at that and that has to be approved by the White House.

Vaccines 125
article thumbnail

UK trial will see if data trumps hype over ivermectin’s role in COVID

pharmaphorum

In March, for example, the World Health Organization (WHO) said there was no evidence of a benefit in COVID-19 and it should not be used outside clinical trials – a view also expressed by the European Medicines Agency (EMA) and National Institutes of Health (NIH) in the US.

Hospitals 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Chinese starts vaccinating key workers against COVID-19; report

pharmaphorum

Zheng Zhongwei, head of China’s COVID-19 vaccine development task force, made the revelation on Chinese television, saying that the vaccines were being used in people at high-risk of contracting SARS-CoV-2, including front-line medical staff, according to the China Daily news service.

article thumbnail

Spotlight on COVID-19 antibody therapies after Trump’s recovery

pharmaphorum

The spotlight remains on the potential of antibody therapies as a possible way out of the COVID-19 pandemic crisis, with the US government investing millions in a hopeful from AstraZeneca and president Donald Trump recovering from coronavirus after receiving a rival therapy from Regeneron. Regeneron CEO Leonard Schleifer.

FDA 98